Herpes simplex virus (HSV) occurs worldwide causing several diseases. There are two herpes antigenic types, type 1 and type 2. Definitive diagnosis of genital herpes infections is fundamental to the management of patients and the development of strategies to prevent transmission to partners and neonates. There has been a world-wide increase in genital herpes during the last twenty years. Accurate diagnosis is key to treatment and prevention of genital herpes. Genital herpes can be diagnosed, treated, and most importantly, may be prevented.
Genital herpes diagnosis has proven inaccurate when based solely on clinical history and impression. Instead, virus, antigen or nucleic acid detection and classification is used for patients presenting with lesions or type-specific serological tests may be used when lesions are absent.
GenBio developed and sells ImmunoWELL, ImmunoDOT and ImmunoFLOW (late 2012) HSV products (Not available in U.S.). These include ImmunoWELL for the reference laboratory and ImmunoDOT for facilities receiving fewer specimens.
Our newest test will be available in late 2012. It detects total HSV and HSV type 2 IgG using GenBio’s convenient and versatile ImmunoFLOW assay platform. (Not available in U.S.)